Changeflow GovPing Courts & Legal Pohlmann v. Blum et al
Routine Enforcement Added Final

Pohlmann v. Blum et al

Favicon for www.cand.uscourts.gov NDCA Recently Filed Documents
Filed
Detected
Email

Summary

Stockholder derivative suit filed against Cytokinetics directors and officers in N.D. California. The case involves allegations related to corporate governance. Recent filings include pro hac vice motions for attorneys and a stipulation to stay the action pending. The case remains in early procedural stages with no substantive ruling issued.

What changed

A stockholder derivative lawsuit was filed against Cytokinetics Incorporated and its directors/officers including Robert I. Blum, Santo J. Costa, and Robert A. Harrington in the Northern District of California. The case was filed on March 9, 2026, under case number 3:26-cv-01998-RFL before Judge Rita F. Lin. Recent procedural filings include pro hac vice motions for attorneys and a joint stipulation to stay the action.

For Cytokinetics and its leadership, this represents ongoing litigation risk requiring defense resources. Stockholder derivative suits typically allege breaches of fiduciary duty, waste, or mismanagement. The parties have already stipulated to stay proceedings, suggesting potential settlement discussions. Directors should ensure D&O insurance coverage is adequate and work with counsel to respond to discovery requests if the stay is lifted.

What to do next

  1. Monitor for case developments
  2. Review corporate governance disclosures

Archived snapshot

Apr 9, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Pohlmann v. Blum et al

Case Number: 3:26-cv-01998-RFL Judge: Lin, Rita F. Location: San Francisco Case Type: Civil Case Basis: Federal Question Nature of Suit: Stockholders Suits Date Filed:

March 9, 2026

Last Filing Date:

April 8, 2026

View Publicly Available Documents Case Summary No summary of this case is available

Recent Filings

| Date Filed | Docket Number | Document Description |
| --- | --- | --- |
| 04-08-26 | 18 | MOTION for leave to appear in Pro Hac Vice ( Filing fee $ 328, receipt number ACANDC-21848423.) Filing fee previously paid on 4/8/2026 filed by Muna Bhanji, Robert I. Blum, Santo J. Costa, Cytokinetics, Incorporated, Robert A. Harrin |
| 04-08-26 | 19 | MOTION for leave to appear in Pro Hac Vice for Andrew Berdon ( Filing fee $ 328, receipt number ACANDC-21849077.) filed by Muna Bhanji, Robert I. Blum, Santo J. Costa, Cytokinetics, Incorporated, Robert A. Harrington, John T. Henders |
| 04-08-26 | 20 | STIPULATION WITH PROPOSED ORDER STAYING ACTION filed by Muna Bhanji, Robert I. Blum, Santo J. Costa, Cytokinetics, Incorporated, Robert A. Harrington, John T. Henderson, Edward M. Kaye, Robert Landry, B. Lynne Parshall, Sandford D. Smith |
| 04-08-26 | 21 | Certificate of Interested Entities by Muna Bhanji, Robert I. Blum, Santo J. Costa, Robert A. Harrington, John T. Henderson, Edward M. Kaye, Robert Landry, B. Lynne Parshall, Sandford D. Smith, Wendell Wierenga, Nancy J. Wysenski (Kap |
| 04-08-26 | 22 | Certificate of Interested Entities by Cytokinetics, Incorporated (Kapur, Emily) |
Return to top

Get daily alerts for NDCA Recently Filed Documents

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NDCA.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
NDCA
Filed
March 9th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
3:26-cv-01998-RFL (N.D. Cal.)
Docket
3:26-cv-01998-RFL

Who this affects

Applies to
Public companies Investors
Industry sector
3254.1 Biotechnology
Activity scope
Derivative litigation Securities claims Corporate governance
Geographic scope
California US-CA

Taxonomy

Primary area
Corporate Governance
Operational domain
Legal
Topics
Securities Judicial Administration

Get alerts for this source

We'll email you when NDCA Recently Filed Documents publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!